Regeneron Announces Secondary Offering of its Common Stock Held by Sanofi and $5 Billion Stock Repurchase
bioportfolio.co.uk TARRYTOWN, N.Y., May 25, 2020 /PRNewswire/BioPortfolio.co.uk/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the commencement of an underwritten public secondary offering of its common stock through which Sanofi (NASDAQ: SNY) intends to exit its investment in Regeneron shares. The shares...
http://dlvr.it/RXKZ0k
http://dlvr.it/RXKZ0k
Comments
Post a Comment